Discern Health Investigates Care Coordination for Multiple Myeloma

August 2020

In a new article in the Journal of Clinical Pathways, Discern Health Partner Tom Valuck, Director David Blaisdell, and co-authors from Tennessee Oncology, Cardinal Health, and Bristol Myers Squibb investigate how a large US community oncology practice views quality in multiple myeloma (MM) care, perceived gaps in care, and potential solutions and measurement opportunities.

This report from the field, “Care Coordination Between Prescribers and the Specialty Pharmacy for Multiple Myeloma: Qualitative Insights into Designing a Quality Improvement Program for Multisite Community Oncology Practices,” chronicles the initial results of this work between a community oncology practice and a drug manufacturer to improve MM care quality.

Read the full article here.

For more information, please contact Gracelena Ignacio at gignacio@discernhealth.com.

Discern expands Health Economics and Outcomes Research (HEOR) Capabilities For Life Sciences clients

Health economics and outcomes research (HEOR) has long been important for health care market access outside the U.S., but it is increasingly being utilized in the U.S. as part of the movement from vol...
Learn More

About

About

Capabilities

Capabilities

Contact

Contact Us

Insights

Insights

Guy D’Andrea Speaks About Innovative Payment Models

Click here to view the VIDEO